Date Document
12/12/2005 FerriScan gains independent validation
29/11/2005 Appendix 3B
29/11/2005 Change of Director's Interest Notice
15/11/2005 Close of SPP & Appointment of U.S. Corporate Advisor
14/11/2005 Results of AGM
14/11/2005 AGM Presentation
03/11/2005 Expands into Fibrosis Field
31/10/2005 Commitments Test Entity - First Quarter Report
25/10/2005 Shareholder Letter
21/10/2005 Notice under Section 708A
21/10/2005 Appendix 3B
14/10/2005 Annual Report/Notice of AGM
12/10/2005 First European Patent Granted
10/10/2005 Share Purchase Plan
06/10/2005 Notice under Section 708A
04/10/2005 Awarded WA State Government Health Supply Contract
30/09/2005 Annual Report
29/09/2005 $1m Placement & Share Purchase Plan
28/09/2005 Trading Halt
22/09/2005 Results of Meeting
22/09/2005 General Meeting Presentation
13/09/2005 Preliminary Final Report
13/09/2005 Signs MOU with major US Radiology Chain
22/08/2005 Notice of General Meeting
16/08/2005 Agreement with US Research Institute to Supply FerriScan
05/08/2005 To provide expanded FerriScan Serv to pharmaceutical company
29/07/2005 Commitments Test Entity - Fourth Quarter Report
06/07/2005 Becoming a substantial holder
06/07/2005 Expansion of Medical Advisory Board
06/07/2005 Investor Update
30/06/2005 Appendix 3B
30/06/2005 Becoming a substantial holder
22/06/2005 Initial Director's Interest Notice
22/06/2005 Initial Director's Interest Notice
16/06/2005 Notice under Section 708A
15/06/2005 Initial Director's Interest Notice
14/06/2005 Becoming a substantial holder
10/06/2005 Placement to Fund Australian Ferriscan
10/06/2005 Revised Appendix 3B
08/06/2005 Appendix 3B
31/05/2005 Presentation - Investor update May 2005
31/05/2005 Results of Meeting
28/04/2005 Notice of General Meeting
28/04/2005 Commitments Test Entity - Third Quarter Report
07/04/2005 Investor Update Presentation
24/03/2005 Cooperate with DCA Group on Commercial Launch of Ferriscan
01/03/2005 Offers to Acquire Remaining 100% of IVB
01/03/2005 Trading Halt
28/02/2005 Half Yearly Report & Half Year Accounts
01/02/2005 Investor Update
01/02/2005 Appendix 3B - Issue & conversion of securities
31/01/2005 Commitments Test Entity - Second Quarter Report
28/01/2005 FDA Approves FerriScan
13/01/2005 Appendix 3B - Conversion of options
06/01/2005 Appendix 3B: Exercise of Options
06/01/2005 Results of General Meeting